47 results on '"Imbs D"'
Search Results
2. 5610823 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
3. Inhibition of OCT2, MATE1 and MATE2-K as a possible mechanism of drug interaction between pazopanib and cisplatin
4. P119: TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
5. P120: TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
6. IgM fluorescence antibodies in sera of pregnant women exposed to rubella
7. A Simple Snapshot Algorithm for Multicore Systems.
8. MANPRINT Risk Assessment
9. IgM fluorescence antibodies in sera of pregnant women exposed to rubella
10. MANPRINT Risk Assessment
11. Individualization of high dose carboplatin with therapeutic drug monitoring and pharmacogenetic markers of toxicity in TICE protocol (testicular germ cell lines)
12. Complement and circulating immune complexes in children with mumps meningitis
13. [Comparative studies of immunogenicity and reactogenicity of various rubella vaccines. II. Seroconversion and post-vaccination reactions in girls immunized against rubella with Rudivax and Cendevax vaccines].
14. [Congenital rubella. 3. A preliminary observations in children born without clinical signs of intrauterine infection].
15. [Seroepidemiological studies for the detection of Cytomegalovirus (CMV) and herpes simplex virus (HSV) infections among girls and women in Poland].
16. [Seroepidemiologic studies of rubella among the population in Poland].
17. [Natural and post-vaccination seroconversion for rubella virus among female medical students and women working in the public health institutions].
18. [Seroepidemiological studies of measles among girls and women in Poland].
19. [Etiopathogenesis and sequelae of viral neuroinfections in children. III. Serodiagnosis of mumps neuroinfections].
20. [Etiopathogenesis and sequelae of viral neuroinfections in children. IV. Etiology and clinical aspects of neuroinfections with a severe course].
21. [Dynamics of changes in the titres of Herpes simplex virus type 1 antibodies in patients treated with long-term dialyses].
22. Cell-mediated immune reactions in measles.
23. [Occurrence of antibodies against Herpes simplex virus type 1 in patients treated by long-term dialysis and in personnel of the dialysis department].
24. [Etiopathogenesis and sequelae of viral neuroinfections in children. I. Principles, materials and methods of study].
25. [Changes in the titre of cytomegalovirus antibodies in patients on long-term dialysis treatment].
26. Postinfection and postvaccination antirubella immunity.
27. Calculation of the frequency of congenital rubella syndrome in Poland.
28. [Bacterial and viral antibodies in human immunoglobulin preparations. II. Viral antibodies].
29. Cell- and antibody-mediated responses to measles and mumps viruses in experimental animals.
30. [Active infections with teratogenic viruses in parturients].
31. [Rubella virus antibodies among girls and women in Poland].
32. [Humoral and cellular immunity to selected viral antigens in children from the Bełchatów Industrial Region].
33. [Comparative studies of the immunogenic and reactogenic properties of various vaccines against rubella. I. Seroconversion and post-vaccination reactions in girls immunized against rubella with Almevax vaccine].
34. Study of interaction between IgG and IgM antibodies against rubella virus by the immunofluorescence method.
35. [Various methods of virologic diagnosis as applied to etiological studies on respiratory infections].
36. The application of different cell lines and virus strains for detection of immunofluorescence rubella antibodies.
37. [Antibodies in the cerebrospinal fluid of patients with mumps meningitis].
38. Complement and circulating immune complexes in children with mumps meningitis.
39. [Occurrence of antibodies against epidemic parotitis virus among the population of Poland].
40. [Cytomegalovirus antibodies in patients and personnel of a hemodialysis unit].
41. [Etiopathogenesis and sequelae of viral neuroinfections in children. II. Etiology and clinical aspects].
42. [Virologic and serologic studies in cases of parotitis epidemica in the city of Warsaw in 1958-1965].
43. [Significance of concomitant viral and bacterial infections in diarrheic conditions].
44. [A CASE OF ADENOVIRUS TYPE 4 INFECTION WITH A SEVERE CLINICAL COURSE].
45. [Epidemiologic analysis of mumps virus infections in the City of Warsaw in the years 1972-1973].
46. [Epidemic of respiratory tract infection in young children caused by type 3 adenovirus].
47. [Pseudodiphtheritic conjunctivitis caused by type 3 Adenovirus].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.